Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?
详细信息    查看全文
Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55–64. This paper presents the most recent population based statistics on the prevalence of chronic widespread pain.CrossRef PubMed PubMedCentral
2.Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015;10(9), e0138024.CrossRef PubMed PubMedCentral
3.Wolfe F, Brähler E, Hinz A, Häuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res. 2013;65(5):777–85.CrossRef
4.Buskila D, Press J, Gedalia A, Klein M, Neumann L, Boehm R, et al. Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol. 1993;20(2):368–70.PubMed
5.Clark P, Burgos-Vargas R, Medina-Palma C, Lavielle P, Marina FF. Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol. 1998;25(10):2009–14.PubMed
6.Gerloni V, Ghirardini M, Fantini F. Assessment of nonarticular tenderness and prevalence of primary fibromyalgia syndrome in healthy Italian schoolchildren. Arthritis Rheum. 1998;41(9):1405.
7.•
Yunus MB, Masi AT. Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls. Arthritis Rheum. 1985;28(2):138–45. The first study that provided recognition of juvenile fibromyalgia as a syndrome in youth and suggested criteria for its proper classification.CrossRef PubMed
8.Gedalia A, Garcia CO, Molina JF, Bradford NJ, Espinoza LR. Fibromyalgia syndrome: experience in a pediatric rheumatology clinic. Clin Exp Rheumatol. 2000;18(3):415–9.PubMed
9.Kashikar-Zuck S, Parkins IS, Ting TV, Verkamp E, Lynch-Jordan A, Passo M, et al. Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford). 2010;49(11):2204–9.CrossRef
10.•
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600–10. The most recent criteria for diagnosis of adult FM which introduced the concept of assessment of widespread pain and somatic symptom severity using standardized rating scale. Also suggested that the tender point exam was not necessary to meet criteria for FM.CrossRef
11.•
Ting TV, Barnett K, Lynch-Jordan A, Whitacre C, Henrickson M, Kashikar-Zuck S. 2010 American College of Rheumatology adult fibromyalgia criteria for use in an adolescent female population with juvenile fibromyalgia. J Pediatr. 2016;169:181–87. This study demonstrated that the ACR 2010 criteria for adult FM could be applied in a sample of adolescent females with JFM with high sensitivity and specificity.
12.Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014;66(9):1364–73.CrossRef
13.•Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, et al. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012;64(1):297–305. This is the only published randomized clinical trial of cognitive-behavioral therapy (CBT) for JFM. Results showed strong improvements in functional disability after an 8-week CBT intervention.CrossRef PubMed PubMedCentral
14.Kashikar-Zuck S, Vaught MH, Goldschneider KR, Graham TB, Miller JC. Depression, coping and functional disability in juvenile primary fibromyalgia syndrome. J Pain. 2002;3(5):412–9.CrossRef PubMed
15.Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944–52.CrossRef PubMed
16.Kashikar-Zuck S, Lynch AM, Slater S, Graham TB, Swain NF, Noll RB. Family factors, emotional functioning, and functional impairment in juvenile fibromyalgia syndrome. Arthritis Rheum. 2008;59(10):1392–8.CrossRef PubMed
17.Kashikar-Zuck S, Parkins IS, Graham TB, Lynch AM, Passo M, Johnston M, et al. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008;24(7):620–6.CrossRef PubMed PubMedCentral
18.Reid GJ, Lang BA, McGrath PJ. Primary juvenile fibromyalgia: psychological adjustment, family functioning, coping, and functional disability. Arthritis Rheum. 1997;40(4):752–60.CrossRef PubMed
19.Kashikar-Zuck S, Johnston M, Ting TV, Graham BT, Lynch-Jordan AM, Verkamp E, et al. Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J Pediatr Psychol. 2010;35(9):996–1004.CrossRef PubMed PubMedCentral
20.Kashikar-Zuck S, Lynch AM, Graham TB, Swain NF, Mullen SM, Noll RB. Social functioning and peer relationships of adolescents with juvenile fibromyalgia syndrome. Arthritis Rheum. 2007;57(3):474–80.CrossRef PubMed
21.Kashikar-Zuck S, Zafar M, Barnett KA, Aylward BS, Strotman D, Slater SK, et al. Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia. Clin J Pain. 2013;29(12):1066–72.CrossRef PubMed
22.Varni JW, Burwinkle TM, Limbers CA, Szer IS. The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes. 2007;5:9.CrossRef PubMed PubMedCentral
23.Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5(1):43.CrossRef PubMed PubMedCentral
24.Kashikar-Zuck S, Flowers SR, Verkamp E, Ting TV, Lynch-Jordan AM, Graham TB, et al. Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain. 2010;11(9):885–93.CrossRef PubMed PubMedCentral
25.Gedalia A, Press J, Klein M, Buskila D. Joint hypermobility and fibromyalgia in schoolchildren. Ann Rheum Dis. 1993;52(7):494–6.CrossRef PubMed PubMedCentral
26.•Ting TV, Hashkes PJ, Schikler K, Desai AM, Spalding S, Kashikar-Zuck S. The role of benign joint hypermobility in the pain experience in juvenile fibromyalgia: an observational study. Pediatric Rheumatol. 2012;10(1):16. This study documented that joint hypermobility is present in ∼40% of adolescent patients with JFM.CrossRef
27.Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr. 1999;135(4):494–9.CrossRef PubMed
28.Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67(8):1219–25.CrossRef PubMed
29.Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40(1):57–63.CrossRef PubMed
30.Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006;124(1–2):117–25.CrossRef PubMed
31.Cunningham NR, Tran ST, Lynch-Jordan AM, Ting TV, Sil S, Strotman D, et al. Psychiatric disorders in young adults diagnosed with juvenile fibromyalgia in adolescence. J Rheumatol. 2015;42(12):2427–33.CrossRef PubMed
32.Buskila D, Neumann L, Hershman E, Gedalia A, Press J, Sukenik S. Fibromyalgia syndrome in children: an outcome study. J Rheumatol. 1995;22(3):525–8.PubMed
33.Mikkelsson M. One year outcome of preadolescents with fibromyalgia. J Rheumatol. 1999;26(3):674–82.PubMed
34.Mikkelsson M, Salminen JJ, Kautiainen H. Non-specific musculoskeletal pain in preadolescents. Prevalence and 1-year persistence. Pain. 1997;73(1):29–35.CrossRef PubMed
35.Siegel DM, Janeway D, Baum J. Fibromyalgia syndrome in children and adolescents: clinical features at presentation and status at follow-up. Pediatrics. 1998;101(3 Pt 1):377–82.CrossRef PubMed
36.•Kashikar-Zuck S, Cunningham N, Sil S, Bromberg MH, Lynch-Jordan AM, Strotman D, et al. Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood. Pediatrics. 2014;133(3):e592–600. This controlled study of the outcomes of JFM patients over a 6-year follow-up period showed that the majority continued to be symptomatic and 51% met full ACR criteria for adult FM.CrossRef PubMed PubMedCentral
37.Arnold LM, Bateman L, Palmer RH, Lin Y. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. Pediatr Rheumatol. 2015;13(1):1–14.CrossRef
38.Mariutto EN, Stanford SB, Kashikar-Zuck S, Welge JA, Arnold LM. An exploratory, open trial of fluoxetine treatment of juvenile fibromyalgia. J Clin Psychopharmacol. 2012;32(2):293–5.CrossRef PubMed
39.Arnold L, Bateman L, Schikler KN, Khan T, Pauer L, Bhadra Brown P, Chew ML, Clair A, Scavone J. A randomized, controlled trial of pregabalin in adolescent patients (12–17 years) with fibromyalgia [abstract]. Arthritis Rheum. 2015;Suppl 10:67.
40.Arnold LM, Sarzi-Puttini P, Arsenault P, Khan T, Bhadra Brown P, Clair A, et al. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J Rheumatol. 2015;42(7):1237–44.CrossRef PubMed
41.Kashikar-Zuck S, Swain NF, Jones BA, Graham TB. Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome. J Rheumatol. 2005;32(8):1594–602.PubMed
42.Bernardy K, Fuber N, Kollner V, Hauser W. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome—a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010;37(10):1991–2005.CrossRef PubMed
43.Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: a meta-analysis. Pain. 2010;151(2):280–95.CrossRef PubMed
44.Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;4, CD003786.PubMed
45.Gowans SE, de Hueck A. Effectiveness of exercise in management of fibromyalgia. Curr Opin Rheumatol. 2004;16(2):138–42.CrossRef PubMed
46.Stephens S, Feldman BM, Bradley N, Schneiderman J, Wright V, Singh-Grewal D, et al. Feasibility and effectiveness of an aerobic exercise program in children with fibromyalgia: results of a randomized controlled pilot trial. Arthritis Rheum. 2008;59(10):1399–406.CrossRef PubMed
47.Kashikar-Zuck S, Flowers SR, Strotman D, Sil S, Ting TV, Schikler KN. Physical activity monitoring in adolescents with juvenile fibromyalgia: findings from a clinical trial of cognitive-behavioral therapy. Arthritis Care Res (Hoboken). 2013;65(3):398–405.CrossRef
48.Sherry DD, Brake L, Tress JL, Sherker J, Fash K, Ferry K, et al. The treatment of juvenile fibromyalgia with an intensive physical and psychosocial program. J Pediatr. 2015;167(3):731–7.CrossRef PubMed
49.Sil S, Thomas S, DiCesare C, Strotman D, Ting T, Myer G, Kashikar-Zuck S. (159) Fear of movement and physical deconditioning in adolescents with juvenile fibromyalgia [Abstract]. J Pain. 2014;15(4 Suppl):15.
50.Sil S, Thomas S, DiCesare C, Strotman D, Ting TV, Myer G, et al. Preliminary evidence of altered biomechanics in adolescents with juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2015;67(1):102–11.CrossRef
51.Rabbitts JA, Holley AL, Karlson CW, Palermo TM. Bidirectional associations between pain and physical activity in adolescents. Clin J Pain. 2014;30(3):251–8.CrossRef PubMed PubMedCentral
52.Nijs J, Kosek E, Van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012;15(3S):ES205–13.PubMed
53.Staud R, Robinson ME, Price DD. Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain. 2005;118(1):176–84.CrossRef PubMed
54.Thomas SM, Sil S, Kashikar-Zuck S, Myer GD. Can modified neuromuscular training support the treatment of chronic pain in adolescents? Strength Cond J. 2013;35(3):12–26.CrossRef
55.•Kashikar-Zuck S, Tran ST, Barnett K, Bromberg MH, Strotman D, Sil S, et al. A qualitative examination of a new combined cognitive-behavioral and neuromuscular training intervention for juvenile fibromyalgia. Clin J Pain. 2016;32(1):70–81. This study describes a new integrative training intervention for the management of JFM which combines CBT with physical exercises based on an injury-prevention approach derived from Sports Medicine to improve movement competence via gait, strength and balance training.CrossRef PubMed
56.Castro‐Sánchez AM, Matarán‐Peñarrocha GA, López‐Rodríguez MM, Lara‐Palomo IC, Arendt‐Nielsen L, Fernández‐de‐las‐Peñas C. Gender differences in pain severity, disability, depression, and widespread pressure pain sensitivity in patients with fibromyalgia syndrome without comorbid conditions. Pain Med. 2012;13(12):1639–47.CrossRef PubMed
57.Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure‐pain thresholds and psychological factors. Arthritis Rheum. 2003;48(10):2916–22.CrossRef PubMed
58.Staud R, Vierck CJ, Robinson ME, Price DD. Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain. 2005;6(5):323–32.CrossRef PubMed
59.Staud R. Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin N Am. 2009;35(2):263–74.CrossRef
60.Staud R. Brain imaging in fibromyalgia syndrome. Clin Exp Rheumatol. 2010;29(6 Suppl 69):S109–17.
61.Ablin JN, Buskila D, Clauw DJ. Biomarkers in fibromyalgia. Curr Pain Headache Rep. 2009;13(5):343–9.CrossRef PubMed
62.Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011;13(6):513–20.CrossRef PubMed
  • 作者单位：Susmita Kashikar-Zuck (1)
    Christopher King (2)
    Tracy V. Ting (3)
    Lesley M. Arnold (4)

    1. Division of Behavioral Medicine and Clinical Psychology, MLC 7039, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA
    2. Department of Pediatric Anesthesia, MLC 7031, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA
    3. Division of Pediatric Rheumatology, MLC 4010, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229-3026, USA
    4. Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3200, Cincinnati, OH, 45219, USA
  • 刊物主题：Rheumatology;
  • 出版者：Springer US
  • ISSN：1534-6307
    • 文摘
    While a majority of research has focused on adult fibromyalgia (FM), recent evidence has provided insights into the presence and impact of FM in children and adolescents. Commonly referred as juvenile fibromyalgia (JFM), youths, particularly adolescent girls, present with persistent widespread pain and cardinal symptoms observed in adult FM. A majority of youth with JFM continue to experience symptoms into adulthood, which highlights the importance of early recognition and intervention. Some differences are observed between adult and juvenile-onset FM syndrome with regard to comorbidities (e.g., joint hypermobility is common in JFM). Psychological comorbidities are common but less severe in JFM. Compared to adult FM, approved pharmacological treatments for JFM are lacking, but non-pharmacologic approaches (e.g., cognitive-behavioral therapy and exercise) show promise. A number of conceptual issues still remain including (1) directly comparing similarities and differences in symptoms and (2) identifying shared and unique mechanisms underlying FM in adults and youths.

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址：北京市海淀区学院路29号 邮编：100083

    电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700